Evaluation of dyslipidemia in the emergency department: Impact of cholesterol testing on subsequent therapy

Andra L. Blomkalns, Elise M. O'Connell, Caroline E. Eady, Christopher J. Lindsell, W. Brian Gibler

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Dyslipidemia is not routinely evaluated in emergency department (ED) patients. We hypothesized that many ED patients would qualify for lipid therapy and that methods of follow-up for patients would not achieve adequate treatment goals. Methods: We performed an observational study of ED patients with symptoms consistent with acute coronary syndrome (ACS). Lipid profiles and data about coronary heart disease risk factors were obtained. The National Institutes of Health/National Cholesterol Education Program guidelines were used to determine whether patients qualified for drug therapy. Six-week and 6-month follow-ups were performed. Results: Three hundred ninety-four patients presenting to the ED with possible ACS were enrolled in the study; 47 patients were subsequently excluded. The remaining 347 included patients who were 63.7% African American and 53.6% female. Proportions of patients with low-density lipoprotein ≥130 and ≥160 were 30.8% and 10.1%, respectively. Fifty-seven (16.4%, 95% CI 12.9%-20.7%) qualified for immediate drug therapy. Of the 44 patients meeting treatment criteria for whom follow-up was obtained, only 1 (2.3%) had received lipid-lowering medications with outpatient referral within 6 weeks. At 6 months, 4 (9.5%) of 42 patients with follow-up had received lipid-lowering therapies. Conclusions: Dyslipidemia meeting criteria for therapy is present in a significant proportion of ED patients. Most of these patients do not get appropriately treated on medical follow-up. Our study suggests that lipid screening and subsequent appropriate lipid-lowering therapy could be considered for ED patients with possible ACS.

Original languageEnglish (US)
Pages (from-to)1182-1186
Number of pages5
JournalAmerican Heart Journal
Volume152
Issue number6
DOIs
StatePublished - Dec 1 2006

Fingerprint

Dyslipidemias
Hospital Emergency Service
Cholesterol
Lipids
Therapeutics
Acute Coronary Syndrome
Drug Therapy
National Institutes of Health (U.S.)
LDL Lipoproteins
African Americans
Observational Studies
Coronary Disease
Outpatients
Referral and Consultation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Evaluation of dyslipidemia in the emergency department : Impact of cholesterol testing on subsequent therapy. / Blomkalns, Andra L.; O'Connell, Elise M.; Eady, Caroline E.; Lindsell, Christopher J.; Gibler, W. Brian.

In: American Heart Journal, Vol. 152, No. 6, 01.12.2006, p. 1182-1186.

Research output: Contribution to journalArticle

Blomkalns, Andra L. ; O'Connell, Elise M. ; Eady, Caroline E. ; Lindsell, Christopher J. ; Gibler, W. Brian. / Evaluation of dyslipidemia in the emergency department : Impact of cholesterol testing on subsequent therapy. In: American Heart Journal. 2006 ; Vol. 152, No. 6. pp. 1182-1186.
@article{7ab02a0975fd498fb30ba1a02586966e,
title = "Evaluation of dyslipidemia in the emergency department: Impact of cholesterol testing on subsequent therapy",
abstract = "Background: Dyslipidemia is not routinely evaluated in emergency department (ED) patients. We hypothesized that many ED patients would qualify for lipid therapy and that methods of follow-up for patients would not achieve adequate treatment goals. Methods: We performed an observational study of ED patients with symptoms consistent with acute coronary syndrome (ACS). Lipid profiles and data about coronary heart disease risk factors were obtained. The National Institutes of Health/National Cholesterol Education Program guidelines were used to determine whether patients qualified for drug therapy. Six-week and 6-month follow-ups were performed. Results: Three hundred ninety-four patients presenting to the ED with possible ACS were enrolled in the study; 47 patients were subsequently excluded. The remaining 347 included patients who were 63.7{\%} African American and 53.6{\%} female. Proportions of patients with low-density lipoprotein ≥130 and ≥160 were 30.8{\%} and 10.1{\%}, respectively. Fifty-seven (16.4{\%}, 95{\%} CI 12.9{\%}-20.7{\%}) qualified for immediate drug therapy. Of the 44 patients meeting treatment criteria for whom follow-up was obtained, only 1 (2.3{\%}) had received lipid-lowering medications with outpatient referral within 6 weeks. At 6 months, 4 (9.5{\%}) of 42 patients with follow-up had received lipid-lowering therapies. Conclusions: Dyslipidemia meeting criteria for therapy is present in a significant proportion of ED patients. Most of these patients do not get appropriately treated on medical follow-up. Our study suggests that lipid screening and subsequent appropriate lipid-lowering therapy could be considered for ED patients with possible ACS.",
author = "Blomkalns, {Andra L.} and O'Connell, {Elise M.} and Eady, {Caroline E.} and Lindsell, {Christopher J.} and Gibler, {W. Brian}",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/j.ahj.2006.07.015",
language = "English (US)",
volume = "152",
pages = "1182--1186",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Evaluation of dyslipidemia in the emergency department

T2 - Impact of cholesterol testing on subsequent therapy

AU - Blomkalns, Andra L.

AU - O'Connell, Elise M.

AU - Eady, Caroline E.

AU - Lindsell, Christopher J.

AU - Gibler, W. Brian

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Background: Dyslipidemia is not routinely evaluated in emergency department (ED) patients. We hypothesized that many ED patients would qualify for lipid therapy and that methods of follow-up for patients would not achieve adequate treatment goals. Methods: We performed an observational study of ED patients with symptoms consistent with acute coronary syndrome (ACS). Lipid profiles and data about coronary heart disease risk factors were obtained. The National Institutes of Health/National Cholesterol Education Program guidelines were used to determine whether patients qualified for drug therapy. Six-week and 6-month follow-ups were performed. Results: Three hundred ninety-four patients presenting to the ED with possible ACS were enrolled in the study; 47 patients were subsequently excluded. The remaining 347 included patients who were 63.7% African American and 53.6% female. Proportions of patients with low-density lipoprotein ≥130 and ≥160 were 30.8% and 10.1%, respectively. Fifty-seven (16.4%, 95% CI 12.9%-20.7%) qualified for immediate drug therapy. Of the 44 patients meeting treatment criteria for whom follow-up was obtained, only 1 (2.3%) had received lipid-lowering medications with outpatient referral within 6 weeks. At 6 months, 4 (9.5%) of 42 patients with follow-up had received lipid-lowering therapies. Conclusions: Dyslipidemia meeting criteria for therapy is present in a significant proportion of ED patients. Most of these patients do not get appropriately treated on medical follow-up. Our study suggests that lipid screening and subsequent appropriate lipid-lowering therapy could be considered for ED patients with possible ACS.

AB - Background: Dyslipidemia is not routinely evaluated in emergency department (ED) patients. We hypothesized that many ED patients would qualify for lipid therapy and that methods of follow-up for patients would not achieve adequate treatment goals. Methods: We performed an observational study of ED patients with symptoms consistent with acute coronary syndrome (ACS). Lipid profiles and data about coronary heart disease risk factors were obtained. The National Institutes of Health/National Cholesterol Education Program guidelines were used to determine whether patients qualified for drug therapy. Six-week and 6-month follow-ups were performed. Results: Three hundred ninety-four patients presenting to the ED with possible ACS were enrolled in the study; 47 patients were subsequently excluded. The remaining 347 included patients who were 63.7% African American and 53.6% female. Proportions of patients with low-density lipoprotein ≥130 and ≥160 were 30.8% and 10.1%, respectively. Fifty-seven (16.4%, 95% CI 12.9%-20.7%) qualified for immediate drug therapy. Of the 44 patients meeting treatment criteria for whom follow-up was obtained, only 1 (2.3%) had received lipid-lowering medications with outpatient referral within 6 weeks. At 6 months, 4 (9.5%) of 42 patients with follow-up had received lipid-lowering therapies. Conclusions: Dyslipidemia meeting criteria for therapy is present in a significant proportion of ED patients. Most of these patients do not get appropriately treated on medical follow-up. Our study suggests that lipid screening and subsequent appropriate lipid-lowering therapy could be considered for ED patients with possible ACS.

UR - http://www.scopus.com/inward/record.url?scp=33845243735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845243735&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2006.07.015

DO - 10.1016/j.ahj.2006.07.015

M3 - Article

C2 - 17161073

AN - SCOPUS:33845243735

VL - 152

SP - 1182

EP - 1186

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 6

ER -